Efficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta-analysis of randomized controlled trials

scientific article

Efficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta-analysis of randomized controlled trials is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1111/1440-1681.12858
P8608Fatcat IDrelease_dirhlu5h2jc2bhx2tqvvdigj6m
P698PubMed publication ID28945935

P50authorShanxin LiuQ95951045
P2093author name stringBin Ni
Xingwei Zhang
Donglai Zhou
Yunyan Jing
P2860cites workMeasuring inconsistency in meta-analysesQ27860655
Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivityQ28196405
Ticagrelor versus clopidogrel in patients with acute coronary syndromesQ29619002
Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndromeQ37103506
P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Q37562606
Efficacy and safety analysis of new P2Y12 inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysisQ38592255
Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study.Q40533249
High-dose clopidogrel versus ticagrelor for treatment of acute coronary syndromes after percutaneous coronary intervention in CYP2C19 intermediate or poor metabolizers: a prospective, randomized, open-label, single-centre trialQ40595293
Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromesQ41158103
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesQ46916589
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSEQ46916592
Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.Q53480416
Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.Q54600153
P433issue2
P921main subjectacute coronary syndromeQ266018
P304page(s)122-126
P577publication date2017-09-25
P1433published inClinical and Experimental Pharmacology and PhysiologyQ5133807
P1476titleEfficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta-analysis of randomized controlled trials
P478volume45

Search more.